CD4 and neoplasm: Hence, CD4 T cells recognizing tumor neoepitopes contribute significantly to the efficacy of several types of immunotherapies in murine models and in cancer patients (Kreiter et al, 2015; Knocke et al, 2016; Sahin et al, 2017).